Mitchell Lawrence Jones
Co-Founder and Chief Scientific Officer,
Pharmaceutical
sensient
Canada
Biography
Mr. Mitchell Lawrence Jones, MD, PhD, is a Co-Founder and Chief Scientific Officer of Micropharma Limited. Dr. Jones has been with the Micropharma Limited since its inception and is the driving force behind Micropharma’s innovation and R&D. He has pioneered novel probiotic selection assays and methods for development which form the basis for the Micropharma's rapidly growing product pipeline. He is well published in peer reviewed journals and has submitted 40 patent applications. He has been instrumental in raising public research support and has secured two successful NRC-IRAP applications awarded to the Micropharma Limited in 2008 for the development of a microencapsulated nitric oxide producing agent containing topical medical device and in 2011 for the development of an oral bacterial formulation for the treatment of diabetes and pre-diabetes. Further, he has successfully collaborated and sponsored four NSERC Engage grants with academic researchers in various fields of natural science and engineering. Throughout his career, Dr. Jones has been the recipient of several prestigious awards for excellence in academics, research and innovation including the Alexander Graham Bell Scholarship, Geddes Prize in Biomedical Engineering, Dean’s Honor List, NSERC PGSA Postgraduate Scholarship, and Martlett Scholarship. He was trained at McGill University, where he holds Degrees in Human Physiology (B Sc), Biomedical Engineering (M Eng and PhD) as well as in Clinical Medicine (MD).
Research Interest
Clinical Medicine , Biomedical Science